Gossamer Bio’s (GOSS) “Outperform” Rating Reiterated at Wedbush
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Wedbush in a research note issued to investors on Friday,Benzinga reports. They presently have a $4.00 target price on the stock. Wedbush’s price objective indicates a potential upside of 284.62% from the stock’s current price. A number of other […]
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Wedbush in a research note issued to investors on Friday,Benzinga reports. They presently have a $4.00 target price on the stock. Wedbush’s price objective indicates a potential upside of 284.62% from the stock’s current price. A number of other […]
